Furthermore, GCs also promote lipogenesis in the liver, which leads to an increase in the secretion of very low density lipoproteins (VLDL)
In sum, much current research is aimed at understanding the endogenous GLP-1 system in the brain, particularly how GLP-1R agonists gain access to certain regions of the brain and their effects once they are in the brain, but the complexity of GLP-1 pathways has so far kept scientists from developing a complete understanding of the system.
Standard injection protocol: Dose: 1 to 2 mg daily Duration: 10 to 20 day cycles Frequency: 1 to 3 cycles per year, spaced 4 to 6 months apart Timing: Evening administration to align with natural melatonin production timing Administration: Subcutaneous or intramuscular Maintenance protocol (sublingual): Daily sublingual sprays between injection cycles Lower bioavailability than injection but convenient for ongoing support The cyclic nature of Epitalon protocols reflects how the peptide works
The peptide appears to enhance cellular resistance to oxidative stress, chemical damage, and other insults
and the red cross denotes receptor antagonism